Acurx Pharma's Phase 2b Study Of Ibezapolstat In C. Difficile Infection On Track

RTTNews | 772 gün önce
Acurx Pharma's Phase 2b Study Of Ibezapolstat In C. Difficile Infection On Track

(RTTNews) - Acurx Pharmaceuticals, Inc. (ACXP), while reporting financial results for the second quarter, on Monday, provided an update on its pipeline progress.

The company's lead antibiotic candidate is Ibezapolstat, which is under a Phase 2b clinical trial in the treatment of C. difficile infection (CDI). Enrollment in this study is underway, and the company anticipates completing enrollment of the 36 patients required for an interim review by an Independent Data Monitoring Committee (IDMC) in the coming months, with only 5 patients more to enrol.

The company also said it is continuing its R&D collaboration with Leiden University Medical Center (Holland) under a previously awarded grant from the Dutch Government of approximately $500,000 to further evaluate the mechanism-of-action of Acurx's inhibitors against the DNA pol IIIC enzyme, which is the bacterial target of its antibiotic pipeline for the systemic treatment (IV and oral) of gram-positive bacterial infections.

For the second quarter, the Company reported a net loss of $3.4 million or $0.28 per share, wider than $2.6 million or $0.26 per share in the prior-year quarter.

Etiketler: ACXP
read more
U.S. Mortgage Applications Growth Slows

U.S. Mortgage Applications Growth Slows

U.S. mortgage applications grew at a modest pace in the week ended September 19 following a surge in the previous week, survey data from the Mortgage Bankers Association showed on Wednesday.
RTTNews | 1s 37 dakika önce
U.S. New Home Sales Unexpectedly Skyrocket To Three-Year High In August

U.S. New Home Sales Unexpectedly Skyrocket To Three-Year High In August

A report released by the Commerce Department on Wednesday showed new home sales in the U.S. unexpectedly skyrocketed to their highest level in well over three years in the month of August. The Commerce Department said new home sales soared by 20.5 percent to an annual rate of 800,000 in August after slumping by 1.8 percent to a revised rate of 664,000 in July.
RTTNews | 1s 39 dakika önce
Bay Street Likely To Open Slightly Higher

Bay Street Likely To Open Slightly Higher

Modestly higher futures point to a slightly positive start for the Canadian market on Wednesday. However, uncertainty about further interest rate cuts by the Fed this year, and worries about valuations may render the mood cautious and limit market's upside.
RTTNews | 3s 51 dakika önce
U.S. Dollar Extends Rise Amid Fed Chair Powell Comments

U.S. Dollar Extends Rise Amid Fed Chair Powell Comments

The U.S. dollar continued to be strong against other major currencies in the European session on Wednesday, weighed down by Federal Reserve Chairman Jerome Powell's comments that equity prices are fairly highly valued by many measures.
RTTNews | 4s 8 dakika önce
FTSE 100 Modestly Lower In Cautious Trade

FTSE 100 Modestly Lower In Cautious Trade

U.K. stocks are turning in a mixed performance in cautious trade on Wednesday. Uncertainty about Fed interest rate outlook, and on comments from Fed Chair Jerome Powell's warning that equity valuations are stretched.
RTTNews | 4s 29 dakika önce